Mauer and colleagues demonstrated that inactivation of IL-6R/IL-6 signaling in myeloid cells of experimental animals attenuates obesity-induced inflammation and insulin resistance by promoting M2 macrophage alternative activation. This evidence concerns the gene IL6R and Obesity.